StockData
ArriVent BioPharma, Inc. logo

ArriVent BioPharma, Inc. (AVBP) stock

AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$10.69−0.87 (-7.53%)

Close on Nov 17, 2026Market cap $527.10MP/E –Yield –

ArriVent BioPharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ArriVent BioPharma's price to book ratio was 1.8× on Nov 11, 2026, against 3.1× a year earlier. Over the last 3 years it ranged from 1.8× to 4.9×, with a median of 3.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.8×−0.9
2025Dec 31, 20252.7×−0.5
2024Dec 31, 20243.2×–

More ArriVent BioPharma figures

See a number that looks wrong?